Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.

Share:
More In Business
Where Does Spotify Go From Here?
Seth Schachner, Managing Director at StratAmericas, weighs in on Spotify earnings and why that headline-grabbing deal with Joe Rogan could be worth that $250 million.
Load More